Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick P J Phillips

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
BMC Medicine|February 25, 2016
Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
BMC Medicine|March 30, 2017
Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trialAdam A Witney, Anna L E Bateson, Amina Jindani, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2022
MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assaysChristian Dide-Agossou, Karen Rossmassler, Justin Reid, et al.
Journal of Clinical Microbiology|May 30, 2014
The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatmentIsobella Honeyborne, Bariki Mtafya, Patrick P J Phillips, et al.
BMC Medicine|February 6, 2016
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
International Journal of Antimicrobial Agents|December 9, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Early bactericidal activity studies for pulmonary tuberculosis: A systematic review of methodological aspectsSimon E Koele, Patrick P J Phillips, Caryn M Upton, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
BMC Medicine|February 25, 2016
Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
BMC Medicine|March 30, 2017
Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trialAdam A Witney, Anna L E Bateson, Amina Jindani, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 22, 2022
MOVER approximated CV: A tool for quantifying precision in ratiometric droplet digital PCR assaysChristian Dide-Agossou, Karen Rossmassler, Justin Reid, et al.
Journal of Clinical Microbiology|May 30, 2014
The molecular bacterial load assay replaces solid culture for measuring early bactericidal response to antituberculosis treatmentIsobella Honeyborne, Bariki Mtafya, Patrick P J Phillips, et al.
BMC Medicine|February 6, 2016
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
International Journal of Antimicrobial Agents|December 9, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.
International Journal of Antimicrobial Agents|March 9, 2023
Early bactericidal activity studies for pulmonary tuberculosis: A systematic review of methodological aspectsSimon E Koele, Patrick P J Phillips, Caryn M Upton, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Pageof 12